Document Detail


Will T-cell therapy for cancer ever be a standard of care?
MedLine Citation:
PMID:  23059871     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Cellular therapies for cancer are showing increasing efficacy but their introduction as a 'standard of care' for these disorders is hampered by technical, regulatory and financial concerns. This review identifies some of the major problems and suggests potential solutions.Cancer Gene Therapy advance online publication, 12 October 2012; doi:10.1038/cgt.2012.74.
Authors:
M K Brenner
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-12
Journal Detail:
Title:  Cancer gene therapy     Volume:  -     ISSN:  1476-5500     ISO Abbreviation:  Cancer Gene Ther.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9432230     Medline TA:  Cancer Gene Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital, Houston, TX, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cytokine-enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous ca...
Next Document:  High-resolution isotope-dilution mass spectrometry using metabolism of isotope-labeled compounds: Ap...